ConductScience.org, home

Paper2479986

Vascular endothelial growth factor is a secreted angiogenic mitogen.

Leung DW and 4 others. Science, 1989. Cited by 4,354 papers, by iCite.

Cite this record

ConductScience Library. Vascular endothelial growth factor is a secreted angiogenic mitogen. Papers, record 2479986. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2479986

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Vascular endothelial growth factor is a secreted angiogenic mitogen.
PubMed
Journal
Science
PubMed
Year
1989
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4,354
iCite
Relative citation ratio, by iCite
113
iCite
Revised in PubMed
2022-04-09
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Leung DWD W
2Cachianes GG
3Kuang WJW J
4Goeddel DVD V
5Ferrara NN

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Endothelium, VascularMajor topic
LymphokinesMajor topic
Neovascularization, PathologicMajor topic
Amino Acid Sequence
Animals
Base Sequence
Blotting, Northern
Cattle
Cell Division
Cloning, Molecular
Gene Library
Humans
Molecular Sequence Data
Sequence Homology, Nucleic Acid
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors

Source PubMed

Download CSV of topics

Cited by1,353

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4,354 citations.

PMIDTitleJournalYearIn PapersSource
42920650Exploratory machine-learning analysis of bevacizumab exposure and circulating VEGF dynamics in patients with cancer.Front Pharmacol2026https://conductscience.org/library/papers/42920650PubMed
42818544Cap-Independent Translation Regulation of VEGF Using CRISPR-dCas13d.bioRxiv2026https://conductscience.org/library/papers/42818544PubMed
42792843The Molecular Basis and Biomarker Potential of the HIF-1α-VEGF-GLUT1 Hypoxia Axis in Laryngeal Squamous Cell Carcinoma.Biomedicines2026https://conductscience.org/library/papers/42792843PubMed
42738409The Immune Landscape of Chondrosarcoma: A Review of Tumor-Related Immune Cells.Cancers (Basel)2026https://conductscience.org/library/papers/42738409PubMed
42577617ETS transcription factor ELK3: Molecular insights and translational horizons in cancer (Review).Oncol Lett2026https://conductscience.org/library/papers/42577617PubMed
42465853Efficacy and safety of immune checkpoint inhibitors combined with anti-angiogenic agents for advanced cervical cancer: A systematic review and meta-analysis.Oncol Lett2026https://conductscience.org/library/papers/42465853PubMed
42455955Mechanisms of VEGFR2 activation by VEGF, neuropilin, and heparin.Sci Adv2026https://conductscience.org/library/papers/42455955PubMed
42426779In vivo and in silico wound healing potential of Cannabis Sativa seed oil through inflammation mediators.BMC Complement Med Ther2026https://conductscience.org/library/papers/42426779PubMed
42386923Base editing-derived models of human WDR34 and WDR60 disease alleles replicate retrograde intraflagellar transport (IFT) and hedgehog signaling defects.Commun Biol2026https://conductscience.org/library/papers/42386923PubMed
42346144The Interplay of Splicing and Metabolism in Cancer.Cells2026https://conductscience.org/library/papers/42346144PubMed
42346131Angiogenic Gene Therapy for Lower Extremity Ischemia: Experimental Advances and Clinical Experience.Cells2026https://conductscience.org/library/papers/42346131PubMed
42165956Angiogenic Doping: Plausible Yet Difficult to Detect.Sports Med2026https://conductscience.org/library/papers/42165956PubMed
42165644Development of Miniprotein Binders to Inhibit VEGF-Induced Corneal Neovascularization.Invest Ophthalmol Vis Sci2026https://conductscience.org/library/papers/42165644PubMed
42156503Adipocytes influence choroidal neovascularization via PRDM16.EMBO Mol Med2026https://conductscience.org/library/papers/42156503PubMed
42068530ANRIL in Cardiovascular Diseases: Expression, Mechanism and Therapeutic Implications.Cardiovasc Drugs Ther2026https://conductscience.org/library/papers/42068530PubMed
42018104Efficacy and safety of second-line fluorouracil, leucovorin, and irinotecan plus ramucirumab according to prior first-line regimens in metastatic colorectal cancer: a multicenter retrospective study.Int J Clin Oncol2026https://conductscience.org/library/papers/42018104PubMed
42016824Gd-EOB-DTPA-Enhanced Magnetic Resonance Imaging for Predicting Immunotherapy Response in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.Liver Cancer2026https://conductscience.org/library/papers/42016824PubMed
42015870Aptamer-Based Delivery Systems for VEGF and NGF Modulation in Ocular Therapies.Adv Healthc Mater2026https://conductscience.org/library/papers/42015870PubMed
42014919Fruquintinib plus sintilimab in advanced cervical cancer: an open-label, multicentre, phase 2 study.Commun Med (Lond)2026https://conductscience.org/library/papers/42014919PubMed
42004816Advancements in targeted therapy for gastric cancer.Ther Adv Gastroenterol2026https://conductscience.org/library/papers/42004816PubMed

See all 1,353 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
VEGFA7422Swiss-Prot's referenceshttps://conductscience.org/library/genes/7422

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2479986

GET https://conductscience.org/api/papers/v1/2479986/cited_by?page=2